Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Positrigo

Positrigo

Positrigo AG is a private nuclear medical imaging start-up based in Zurich, Switzerland, founded by Max Ahnen, Jannis Fischer, Alfred Buck, Guenther Dissertori, Werner Lustermann and Bruno Weber. Positrigo is focusing on developing ultra-compact PET systems. Positrigo's technology, development and clinical program are supported by investors 4FO Venture Partners, Great Filter Ventures, Zuercher Kantonalbank (ZKB), ETH Zurich Foundation and Venture Kick. Positrigo is further supported by the European Union research and innovation program Horizon 2020 (grant nos. 855292 and 953844), and by Innosuisse. The BPET prototype was developed at ETH Zurich with the generous support of an ETH Zurich Pioneer Fellowship, of Innosuisse, of the ETH Zurich Foundation, and of Dr. Stephan and Dr. Viktoria Schmidheiny.

Last updated on

About Positrigo

Founded

2018

Estimated Revenue

$0-$1M

Employees

11-50

Funding / Mkt. Cap

$14M

Category

Industry

Medical Devices

Location

City

Zürich

State

Zurich

Country

Switzerland
Positrigo

Positrigo

Find your buyer within Positrigo

Tech Stack (38)

search